Seller record · Telehealth service

Boston Medical Group

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S2, prescription gating: The NAD+ injectable, sermorelin and PT-141 product pages each carry an add-to-cart button beside the price. The weight loss pages start with a visit, and the answers page says a visit begins with medical questions. 2 more criteria also fail; see the table below.

At a glance

Boston Medical GroupTelehealth service

5/8criteria passed

Price: Semaglutide from $99 a month, tirzepatide from $149
Sells: compounded semaglutide, compounded tirzepatide, sermorelin, and 7 more
FDA letters: None on file

Visit Boston Medical Group See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A men's health telemedicine brand centered on erectile dysfunction care that also sells compounded semaglutide and tirzepatide at one price for every dose, plus sermorelin, NAD+, glutathione and PT-141. Its peptide product pages carry add-to-cart buttons, and it names two filling pharmacies.

Operating entity Boston Medical Group Telemedicine LLC The brand sells from 2 storefronts of its own, recorded here as one entry: Boston Medical Group's website, Boston Medical Group's Rx storefront.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Boston Medical Group's weight loss page on its Rx storefront; Boston Medical Group's FAQ on its Rx storefront
S2	Prescription gating	FAIL	Boston Medical Group's NAD+ injectable product page on its Rx storefront; Boston Medical Group's sermorelin product page on its Rx storefront; Boston Medical Group's PT-141 product page on its Rx storefront; Boston Medical Group's FAQ on its Rx storefront
S3	Pharmacy identification	PASS	Boston Medical Group's FAQ on its Rx storefront; Boston Medical Group's contact page
S4	Compounding disclosure	FAIL	Boston Medical Group's PT-141 product page on its Rx storefront; Boston Medical Group's weight loss page on its Rx storefront; the Drugs@FDA record
S5	Analytical documentation	FAIL	Boston Medical Group's weight loss page on its Rx storefront; Boston Medical Group's FAQ on its Rx storefront
S6	Business address	PASS	Boston Medical Group's contact page; Boston Medical Group's terms; Boston Medical Group's privacy policy
S7	Price disclosure	PASS	Boston Medical Group's weight loss page on its Rx storefront; Boston Medical Group's NAD+ injectable product page on its Rx storefront; Boston Medical Group's sermorelin product page on its Rx storefront; Boston Medical Group's PT-141 product page on its Rx storefront
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSPrescription products require an online consultation with a healthcare provider who decides whether a prescription is appropriate, and the answers page says US-based doctors review each patient's medical answers before prescribing.Source: Boston Medical Group's weight loss page on its Rx storefront; Boston Medical Group's FAQ on its Rx storefront.

S2FAILThe NAD+ injectable, sermorelin and PT-141 product pages each carry an add-to-cart button beside the price. The weight loss pages start with a visit, and the answers page says a visit begins with medical questions.Source: Boston Medical Group's NAD+ injectable product page on its Rx storefront; Boston Medical Group's sermorelin product page on its Rx storefront; Boston Medical Group's PT-141 product page on its Rx storefront; Boston Medical Group's FAQ on its Rx storefront.

S3PASSThe answers page names two filling pharmacies: Manifest Pharmacy at 1018 S. Batesville Road, Greer, SC 29650, and RX Compounding Store at 8950 SW 74th Ct, Suite 101, Miami, FL 33156, which the contact page also lists as its dispensing pharmacy.Source: Boston Medical Group's FAQ on its Rx storefront; Boston Medical Group's contact page.

S4FAILThe page selling its PT-141 bremelanotide injection says PT-141 is FDA-approved for hypoactive sexual desire disorder in premenopausal women. The one approved bremelanotide is Vyleesi, an autoinjector; an injection sold here is not that product. The weight loss page and the footer state that compounded medications are not FDA-approved, which does not withdraw the claim.Source: Boston Medical Group's PT-141 product page on its Rx storefront; Boston Medical Group's weight loss page on its Rx storefront; the Drugs@FDA record.

S5FAILNo certificate of analysis or lot document is published on the product pages, the answers page or the policies.Source: Boston Medical Group's weight loss page on its Rx storefront; Boston Medical Group's FAQ on its Rx storefront.

S6PASSBoston Medical Group Telemedicine at 5772 Bolsa Ave #210, Huntington Beach, CA 92649, printed as the corporate office in the footer and in the terms. The privacy policy gives a Costa Mesa address for its privacy officer.Source: Boston Medical Group's contact page; Boston Medical Group's terms; Boston Medical Group's privacy policy.

S7PASSCompounded semaglutide as low as $99 a month and compounded tirzepatide as low as $149 a month, the same price for every dose, while the same page also says doctor-led plans start at $190 a month. NAD+ injectable at $199 a month, sermorelin at $195 and the PT-141 injection at $349.Source: Boston Medical Group's weight loss page on its Rx storefront; Boston Medical Group's NAD+ injectable product page on its Rx storefront; Boston Medical Group's sermorelin product page on its Rx storefront; Boston Medical Group's PT-141 product page on its Rx storefront.

S8PASSNo FDA warning letter names Boston Medical Group or Boston Medical Group Telemedicine, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, sermorelin, NAD+ injectable, glutathione, Bremetide (PT-141, bremelanotide injection), testosterone injectable, Erexafil (tadalafil, sildenafil and apomorphine), ICP injections for erectile dysfunction, hair loss treatment.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione Who sells PT-141

Visit Boston Medical Group

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.